Valuation CASI Pharmaceuticals, Inc. Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 10:13:45 2026-07-28 EDT			5-day change	1st Jan Change
0.1388 ^USD	+7.76%		+2.81%	-83.67%

06-02	CASI Pharmaceuticals, Inc. Announces Resignation of Barbara Krebs-Pohl as Director, Effective May 31, 2026	CI
05-15	CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	365.6	111.8	24.35	95.38	43.84	17.47
Change	-	-69.41%	-78.22%	291.63%	-54.03%	-60.16%
Enterprise Value (EV) ¹	302.5	65.43	-25.64	85.85	49.89	39.32
Change	-	-78.37%	-139.18%	434.86%	-41.88%	-21.19%
P/E	-6.75x	-2.96x	-0.59x	-3.55x	-1.11x	-0.33x
PBR	4.48x	1.32x	0.54x	3.96x	23.7x	-0.47x
PEG	-	0.1x	-0.1x	0.1x	-0x	-0.26x
Capitalization / Revenue	24.1x	3.71x	0.56x	2.82x	1.54x	0.84x
EV / Revenue	20x	2.17x	-0.59x	2.53x	1.75x	1.9x
EV / EBITDA	-9.65x	-1.96x	1.07x	-3.99x	-1.35x	-0.95x
EV / EBIT	-9.08x	-1.85x	0.97x	-3.4x	-1.27x	-0.92x
EV / FCF	-11.7x	-2.39x	1.47x	-6.26x	-3.28x	-60.4x
FCF Yield	-8.55%	-41.8%	67.9%	-16%	-30.5%	-1.66%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-4.372	-2.7	-3.01	-2.018	-2.56	-2.592
Distribution rate	-	-	-	-	-	-
Net sales ¹	15.14	30.17	43.11	33.88	28.54	20.71
EBITDA ¹	-31.35	-33.47	-24.07	-21.54	-36.88	-41.59
EBIT ¹	-33.31	-35.28	-26.49	-25.28	-39.21	-42.85
Net income ¹	-48.29	-36.65	-41.01	-26.94	-39.26	-48.06
Net Debt ¹	-63.18	-46.41	-49.99	-9.53	6.05	21.85
Reference price ²	29.5000	8.0000	1.7900	7.1600	2.8300	0.8500
Nbr of stocks (in thousands)	12,394	13,980	13,606	13,322	15,493	20,548
Announcement Date	3/30/21	3/28/22	4/26/23	3/28/24	3/31/25	5/15/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.56x	12.7x	26.67x	0.56%	1,068B
JOHNSON & JOHNSON	28.51x	6.52x	18.04x	2.02%	641B
ABBVIE INC.	32.33x	7.59x	15.6x	2.68%	454B
ROCHE HOLDING AG	19.49x	4.75x	11.79x	2.78%	351B
NOVARTIS AG	22.29x	5.76x	14.37x	2.78%	299B
ASTRAZENECA PLC	21.47x	4.5x	12.72x	1.93%	266B
NOVO NORDISK A/S	14.4x	5.35x	11.02x	3.48%	220B
AMGEN INC.	24.71x	6.49x	11.44x	2.68%	203B
GILEAD SCIENCES, INC.	-47.03x	5.64x	31.15x	2.53%	162B
Average	16.86x	6.59x	16.98x	2.38%	407.04B
Weighted average by Cap.	24.76x	7.96x	18.76x	1.95%